Guardian Australia, Tuesday 26 September 2017 11.21 AEST Misplaced concerns and myths about long-acting reversible contraceptives have prompted medical experts to release Australia’s first consensus statement, saying they are more reliable and effective than condoms or the pill. Despite their safety, efficacy and widespread use internationally, the uptake of long-acting reversible contraceptives...
The Conversation, July 31, 2017 4.05pm AEST The World Health Organisation recently set ambitious goals for the “elimination of hepatitis C as a major public health threat”. These included having 80% of people treated and an 80% reduction in the spread of the virus by 2030. Given there are around 70 million people infected with hep C worldwide, only 20% diagnosed, and no effective vaccine, the...
Kirby Institute/UNSW – 21 February 2017
More Australians were treated for their hepatitis C infection in the first year new generation hepatitis C regimens were made available on the Pharmaceutical Benefits Schemes than in the past decade, according to a new report released today by the Kirby Institute at UNSW Sydney.
Read more here
Download report (PDF) here
Gay News Network, Wednesday 18 January 2017 The Victorian AIDS Council has announced it will give an additional $100,000 to the PrEPX trial to fund access to pre-exposure prophylaxis for HIV (PrEP) for 600 Victorians at risk. VAC’s announcement comes months after PrEPX reached capacity for men living in metropolitan Melbourne. The VAC said there is already a substantial waiting list for those...
Jay Weatherill MP, Nat Cook MP, Wednesday, November 29, 2016 South Australians at high risk of contracting HIV will have access to the latest preventative technology study, as part of a State Government commitment announced today. Pre-exposure prophylaxis or PrEP is the latest prevention therapy in the fight against HIV. Under a PrEP access trial, eligible South Australians who don’t have HIV and...
Australian Federation of AIDS Organisations (AFAO), 23 August, 2016 Following the Pharmaceutical Benefits Advisory Committee (PBAC) decision not to recommend funding PrEP through the Pharmaceutical Benifits Scheme (PBS), AFAO has produced an Australian PrEP roundup paper to sustain advocacy efforts and to raise awareness about current options for accessing PrEP around the country. In releasing...